Dermatology · Boston, MA
NPI
1679986830
Since 2014
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
221 Longwood Ave
Boston, MA, 02115
Phone (617) 732-4918
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,121 services
Medicare patients, 2024
333
Average age 71
Drug cost, 2024
$3.1M
1,222 prescriptions
Company payments, 2025
$11K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexandra Charrow was code 17003 (destruction skin lesion), 251 times for 62 patients. In total Alexandra Charrow billed 1,121 services in 54 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 251 | 62 | $5.73 | $1,439 |
| 99214 Office E&M - Established | Office | 249 | 167 | $89.99 | $22K |
| 17000 Destruction Skin Lesion | Office | 99 | 82 | $44.87 | $4,443 |
| 99213 Office E&M - Established | Office | 90 | 85 | $65.16 | $5,864 |
| 11102 Skin Biopsy | Office | 68 | 63 | $69.14 | $4,701 |
| 99215 Office E&M - Established | Office | 67 | 39 | $118.52 | $7,941 |
| 11103 Skin Biopsy | Office | 42 | 34 | $36.95 | $1,552 |
| 99212 Office E&M - Established | Office | 35 | 35 | $35.59 | $1,246 |
| 11900 Skin | Office | 26 | 16 | $30.12 | $783 |
| 99204 Office E&M - New | Office | 21 | 21 | $115.69 | $2,429 |
| 17110 Destruction Skin Lesion | Office | 21 | 18 | $76.72 | $1,611 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 16 | 16 | $13.56 | $217 |
By year: 2022 $62K for 959 services; 2023 $66K for 1,079 services; 2024 $67K for 1,121 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexandra Charrow prescribed most often to Medicare patients was Cosentyx Sensoready (2 Pens) (Secukinumab), with 98 prescriptions and refills. In total Alexandra Charrow wrote 1,222 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cosentyx Sensoready (2 Pens) Secukinumab | 98 | 98 | 11 | $1.0M |
| Doxycycline Monohydrate Generic | 67 | 80 | 26 | $1,634 |
| Ketoconazole Generic | 63 | 79 | 34 | $905 |
| Triamcinolone Acetonide Generic | 52 | 65 | 39 | $613 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 48 | 52 | 32 | $2,818 |
| Otezla Apremilast | 47 | 47 | Under 11 | $221K |
| Prednisone Generic | 42 | 49 | 23 | $281 |
| Rinvoq Upadacitinib | 41 | 47 | Under 11 | $352K |
| Clobetasol Propionate Generic | 41 | 51 | 21 | $3,481 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 40 | 42 | 20 | $745 |
| Spironolactone Generic | 35 | 96 | 13 | $782 |
| Metronidazole Generic | 33 | 42 | 21 | $1,503 |
| Clindamycin Phosphate Generic | 33 | 33 | 14 | $1,002 |
| Dupixent Syringe Dupilumab | 32 | 32 | Under 11 | $145K |
| Mupirocin Generic | 30 | 32 | 21 | $265 |
Brand drugs: 389 claims; generic drugs: 833 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexandra Charrow $11K ($11K in general payments such as food, travel and fees) from 2 companies. The largest payer was Incyte Corporation with $9,394.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.